Replies to LegCo questions
LCQ5: Preventive health screening for early detection of cancer
Following is a question by the Hon Chan Kin-por and a reply by the Secretary for
Food and Health, Dr York Chow, in the Legislative Council today (February 8):
Question:
While the number of new cancer cases in Hong Kong surged by about 22% in the
decade since 2000, the number of radiological imaging scan, which is a crucial
tool for diagnosing cancer and assessment of cancer stages, performed in Hong
Kong was much lower than those in other places. Studies conducted by the
Columbia University of the United States (US) reveal that the breakthrough in
cancer imaging technologies resulted in a drop in the number of cancer-related
deaths in US by 40% in a period of 10 years. Based on the figures of the
Hospital Authority (HA) and the ratio of around nine to one for the number of
people using public medical services to those using private medical services, it
is projected that in 2010-2011, the average number of Magnetic Resonance Imaging
(MRI) scans performed in Hong Kong per 1,000 population was about 18.3, which
was two to four times lower than those in most member countries of the
Organisation for Economic Co-operation and Development (OECD) in 2009 (e.g. 75.5
in Iceland, 55.2 in France and 43 in Canada). Similarly, the average number of
Computed Tomography (CT) scans performed in that year was about 77.5 per 1,000
population, which was much lower than the numbers of 156.2 in Iceland, 138.7 in
France and 125.4 in Canada. In this connection, will the Government inform this
Council:
(a) given the significant increase in new cancer cases in Hong Kong in recent
years, and that compared to the numbers five years ago, the numbers of MRI and
CT scans performed in 2010-2011 at the hospitals under HA had already increased
by about one-fifth and one-third respectively, why such numbers still lagged far
behind those in the aforesaid countries;
(b) given that according to the information of OECD, in 2010, there were 22.6
MRI machines per one million population in Greece and 42.5 CT machines per one
million population in Australia, whether it knows the respective numbers of MRI
and CT machines per one million population in Hong Kong at present; as it has
been reported that last year, Tuen Mun Hospital admitted that some non-urgent
patients had to wait for eight years before they could use the MRI scanning
service, whether this was caused by insufficient equipment or manpower; and
(c) given that of the aforesaid rate of increase in new cancer cases, the rate
of increase in the two age groups of 45 to 64 and 65 or above was 44% and 17%
respectively, whether the authorities have put forward any targeted measure to
reduce the cancer risks of people in these two age groups; in addition, given
that according to the statistics of the American Cancer Society, the rate of
increase in the number of new cancer cases in Hong Kong in the five years since
2005 almost doubled the corresponding rate of increase in US, whether the
authorities have analysed the numbers and recent trends of cancer cases in Hong
Kong and in other places, and compared in depth the environmental, lifestyle and
genetic differences so as to identify the causes of the higher rate of increase
in Hong Kong as compared to other places, and reduce the incidence of cancers at
the macro policy level?
Reply:
Acting Madam President,
Cancer is a major public health concern in Hong Kong. In 2009, there were nearly
26,000 newly diagnosed cancer cases. To fight against cancer with the public in
an effective manner, the measures adopted by the Government and the Hospital
Authority (HA) must be scientifically justified and accord with the actual
situation. Before I respond to the question, I would like to clarify on a few
points here -
(i) Firstly, the preamble of the question refers to a study from the Columbia
University of the United States (US). The information that we have gathered
shows that a doctor from the Columbia Business School published a study in 2010,
holding the conclusion that between 1996 and 2006, the age-adjusted cancer
mortality rates in the US declined by 13.4%, with about 40% of the decline (that
is 5.4%) attributable to imaging innovation. The study did not conclude that
imaging technologies resulted in a drop in the number of cancer-related deaths
by 40%.
(ii) Secondly, the question draws reference to some data provided by the
Organisation for Economic Cooperation and Development (OECD). According to the
relevant report, the data provided by various countries did not share a common
basis. For instance, some excluded private sector services; some only covered
organisations eligible for reimbursement under their health protection system;
while some excluded the public sector. With regards the data of the US, OECD
pointed out that there seemed to be an overuse of computer tomography (CT) and
magnetic resonance imaging (MRI) examinations, possibly because of payment
incentives that allowed doctors to benefit from exam referrals.
There are also differences between Hong Kong and countries mentioned in the
question in terms of social infrastructures and healthcare systems. For example,
in Europe and America, the total health expenditure in some countries forms a
steep double-digit percentage of gross domestic product, bringing immense
pressure to the Government's finances and healthcare system. On the other hand,
the figure for Hong Kong is at 4.8%, yet our health statistics still compare
favourably with other developed countries.
Moreover, the demographics, health circumstances, disease incidence and
geographical settings of Hong Kong are also different to the countries mentioned
in the question. In using medical technology, healthcare personnel of different
places may also have received different training, adopted different practices
and face different incentives. In this connection, it is not appropriate to use
OECD data for direct comparison on the number of CT and MRI scanners or the
number of scans performed each year.
(iii) Thirdly, the question assumes a 9:1 ratio for the use of radiological
imaging facilities and services between the public and private sectors. This
estimation is only valid for in-patient services in the public and private
healthcare sectors. There is a substantial number of out-patients in Hong Kong
who receive CT or MRI scan services in the private sector.
My reply to the three parts of the question is as follows:
(a) As mentioned above, the number of MRI and CT scans performed in public
hospitals cannot be compared with the figures provided by OECD. As far as public
hospitals are concerned, doctors will arrange for CT or MRI scans based on
patients' clinical needs. All new cancer cases will be included in the priority
category if such services are needed for assessment of cancer stages.
(b) According to the Irradiating Apparatus Licensing Service of the Department
of Health (DH), as at February 1, 2012, there are 83 units of licensed medical
CT systems across the territory. As MRI scanners are not irradiating apparatuses
and not subject to statutory licensing control, we do not have statistics on the
number of scanners in Hong Kong. As regards HA, it will have 28 CT scanners and
14 MRI scanners in 2011/12. HA plans to procure an additional CT scanner in
Princess Margaret Hospital and an additional MRI scanner in Caritas Medical
Centre in 2012/13. Hospitals will also continue to implement flexible measures
to improve radiological diagnostic services, such as employment and retention of
staff, recruitment of radiographers from overseas or provision of additional
service sessions.
(c) Generally speaking, ageing is a risk factor for common cancers. With a
growing and ageing population in Hong Kong, the actual number of new cancer
cases will continue to rise. On the other hand, it should be noted that the age
composition and other demographic characteristics of places can vary. Between
2000 and 2009, Hong Kong's population in the "45 to 64" and "65 or above" age
groups grew at almost double the rate of the US. For this reason, a direct
comparison in the number of new cancer cases or the rate of increase between two
places cannot reflect the risk of cancers or the actual impact of the disease.
In statistics or epidemiology, we refer to the age-standardised incidence and
mortality rates calculated using the same standard population, in order to make
a meaningful assessment of the figures. Hong Kong has seen declining trends in
both age-standardised incidence and mortality risk of cancers.
In 2001, the Government established a high-level multi-disciplinary Cancer
Coordinating Committee, overseeing and advising on prevention and control of
cancer in Hong Kong. The Committee is chaired by me and comprises of cancer
experts from the public and private sectors.
The Cancer Expert Working Group on Cancer Prevention and Screening under the
Committee reviews the scientific evidence and provides recommendations on
preventive measures and screening of major cancers. For example, according to
scientific evidence, we have implemented a cross-territorial cervical screening
programme with a view to achieving early diagnosis of cervical cancer. We have
also implemented Hepatitis B vaccination for prevention of liver cancer.
In addition, the Hong Kong Cancer Registry of HA serves as a well-established
surveillance system. It captures and analyses statistical cancer data of the
population, and provides predictions on major cancers facilitating healthcare
service planning. On the other hand, DH regularly captures risk-related
behavioural risk factors of the Hong Kong adult population through the
Behavioural Risk Factor Surveillance System. It collects information such as
smoking habits, vegetable consumption, physical activities, use of alcohol,
cervical screening practices. This provides evidence that helps us evaluate our
health promotion and cancer prevention programmes.
According to World Health Organisation's estimation, 40% of the cancer deaths
could be avoided by leading a healthy lifestyle, such as not smoking, pursuing a
healthy diet and regular physical exercise. Although the percentage of cigarette
smokers in Hong Kong has dropped from 23% in early 1980s to 11% at present,
there is no room for complacency. We will continue our efforts in tobacco
control. DH will continue to launch health education initiatives to promote
healthy lifestyles.
The Government also places emphasis on effective treatment in order to stop the
progression of disease after its occurrence. HA has been committed to
radiological treatment services which provide timely and adequate treatment for
suitable patients. On the other hand, while HA has been expanding the coverage
of the Drug Formulary in recent years, more cancer treatment drugs have been
included on a gradual basis and are provided to patients at standard fees and
charges. The Government has also provided additional resources to HA to meet
increasing drug expenditures. From August 1, 2011, eligible patients can apply
to the medical assistance projects under the Community Care Fund, for financial
assistance in using cancer drugs that are not yet included in the Safety Net
supported by the Samaritan Fund.
HA has also launched a pilot scheme at a number of its clusters for case
management of cancer patients. Under the scheme, a consolidated cancer treatment
plan is jointly devised by a team of multi-disciplinary professionals.
Preliminary evidence suggests that patients are generally content with the
cancer case management services.
Under the joint efforts of the Government, the healthcare sector and the
community, Hong Kong's cancer incidence, mortality and survival rates are
comparable to developed countries and regions.
Ends/Wednesday, February 8, 2012
Issued at HKT 16:48
NNNN